| Thomson Reuters Newport Premium |
| Search Results |
| | | | | | | | | | | | | | | |
| Active Ingredients | Local Brand Name | Local Marketers | Merck TC | EphMRA TC | Route of Administration | Dose Form | Newport Constraint Date | First SPC Expiry Date | First Priority Date | First Product Patent Estimated Expiry | Therapeutic Uses | Technology | CAS Number | Studied In |
| adefovir dipivoxil阿德福韦酯 | HEPSERA | GILEAD SCIENCES | Antiviral | Antivirals For Systemic Use; Systemic Antibacterials | Oral | Tablet | 2-Sep-14 | | 25-Apr-85 | 25-Apr-06 | Type B viral hepatitis, chronic (A, P) | Crystalline form; Systemic formulation unspecified; Small molecule therapeutic; Prodrug; Nucleotide and derivatives | 142340-99-6 | Cytomegalovirus infection ox virus infection;Neoplasm;Hepatitis virus infection;Hepatitis B virus infection;HIV infection |
| almotriptan malate依来曲普坦 | AXERT | ORTHO PHARM | Antimigraine; Serotonin Receptor Agonist | Analgesics | Oral | Tablet | 7-Nov-15 | | 28-Jul-92 | 7-May-15 | Migraine (A) | Oral formulation; Small molecule therapeutic | 181183-52-8 | Migraine |
| arformoterol tartrate酒石酸阿福特罗 | BROVANA | SUNOVION | Bronchodilator; Antiasthmatic | Anti-Asthma and COPD Products | Inhale | Aerosol | 12-Nov-16 | | 5-Apr-91 | 11-Nov-16 | Chronic obstructive pulmonary disease (A) | Aerosol formulation, inhalant; Stereochemistry; Small molecule therapeutic; Inhalant formulation | 200815-49-2 | Asthma;Chronic obstructive pulmonary disease |
| argatroban阿加曲班 | Launched with generic name | GSK PHARM | Antithrombotic; Anticoagulant | Antithrombotic Agents; Cardiac Therapy | Parenteral | Injectable | 30-Jun-14 | | 14-Oct-75 | 19-Apr-94 | Coronary artery thrombosis, In patients with or at risk for heparin-induced thrombocytopenia; Prophylaxis - Percutaneous coronary intervention (A); Heparin-induced thrombocytopenia; Treatment and Prophylaxis - Heparin-induced thrombocytopenia with thrombosis (A) | Injectable formulation; Small molecule therapeutic; Parenteral formulation unspecified | 141396-28-3 | Angina;Thrombosis;Thromboembolism;Myocardial infarction;Heparin induced thrombocytopenia;Deep vein thrombosis;Cerebrovascular ischemia;Cerebral infarction |
| aripiprazole阿立哌唑 | ABILIFY | OTSUKA AMERICA PH | Antipsychotic; Dopamine-Serotonin System Stabilizer | Psycholeptics | Oralarenteral | Injectable;Tablet, Orally Disintegrating;Tablet;Liquid | 20-Apr-15 | | 30-Mar-78 | 29-Mar-05 | Autistic disorder - Psychomotor agitation (P); Schizophrenia (A, P); Psychomotor agitation - Schizophrenia (A); Major depressive disorder, Adjunctive treatment in patients also receiving antidepressants (A); Bipolar I disorder, Monotherapy, manic or mixed episodes (A, P); Bipolar I disorder, Adjunctive therapy with lithium or valproate for acute manic or mixed episodes (A, P); Bipolar disorder - Psychomotor agitation (A) | Injectable formulation; Tablet formulation; Sustained release formulation; Small molecule therapeutic; Parenteral formulation unspecified; Oral quick release formulation; Oral liquid formulation; Oral formulation; Intramuscular formulation | 129722-12-9 | Attention deficit hyperactivity disorder;Tourette syndrome;Schizophreniaervasive child developmental disorder;Major depressive disorder;Drug dependence;Bipolar disorder;Autism |
| atazanavir sulfate阿扎那韦 | REYATAZ | BRISTOL-M SQ HIV | Antiviral; HIV Proteinase Inhibitor | Antivirals For Systemic Use; Blood Coagulation System, Other Products | Oral | Capsule | 20-Jun-17 | | 5-May-92 | 9-Apr-17 | HIV infection (A, P) | Capsule formulation; Small molecule therapeutic; Peptidomimetic; Oral formulation | 229975-97-7 | HIV-1 infection |
| bendamustine hydrochloride苯达莫司汀 | TREANDA | CEPHALON INC. | Antineoplastic | Analgesics; Antineoplastics | Parenteral | Injectable | 20-Mar-15 | | 9-Aug-00 | | Chronic lymphoid leukemia (A); Non-Hodgkin's lymphoma, Indolent B-Cell, refractory to rituximab or rituximab-containing regimens (A) | Infusion; Small molecule therapeutic; Intravenous formulation | 3543-75-7 | |
| bepotastine benzenesulfonate salt贝托司汀 | BEPREVE | ISTA PHARM | Antihistaminic | Anti-Asthma and COPD Products; Systemic Antihistamines; Ophthalmologicals | Ophthalmic | Liquid/Drops | 25-Dec-17 | | 26-Dec-96 | 25-Dec-17 | | | 190786-44-8 | Allergic conjunctivitis;Urticaria;Seasonal allergic rhinitis;Respiratory disease;Atopic dermatitis;Allergy;Allergic rhinitis |
| bimatoprost比马前列素 | LUMIGAN | ALLERGAN | Antiglaucoma; Prostaglandin/Prostaglandin Analog | Ophthalmologicals | Ophthalmic | Liquid/Drops | 20-Aug-14 | | 21-Sep-92 | 21-Sep-12 | Hypotrichosis, Of the eyelashes (A); Open-angle glaucoma - Raised intraocular pressure (A); Ocular hypertension - Raised intraocular pressure (A) | Ophthalmic formulation; Small molecule therapeutic; Ophthalmic liquid formulation | 155206-00-1 | Glaucoma |
| bortezomib硼替佐米 | VELCADE | MILLENNIUM PHARM | Antineoplastic | Antineoplastic And Immunomodulating Agents; Antineoplastics | Parenteral | Injectable | 28-Oct-14 | | 28-Oct-94 | 28-Oct-14 | Mantle cell lymphoma, In patients who have received at least 1 prior therapy (A); Multiple myeloma (A) | Infusion; Subcutaneous formulation; Small molecule therapeutic; Intravenous formulation | 179324-69-7 | Acute myelogenous leukemia;Squamous cell carcinoma;Solid tumor;Ovary tumor;Non-small-cell lung cancer;Non-Hodgkin lymphoma;Multiple myeloma;Mantle cell lymphoma;Macroglobulinemia;Hormone refractory prostate cancer;Graft versus host disease;Follicle center lymphoma;Diffuse large B-cell lymphoma;Colorectal tumor;Chronic lymphocytic leukemia;Cerebrovascular ischemia;Breast tumor;Amyloidosis |
| bosentan波生坦 | TRACLEER | ACTELION PHARM | Cardiotonic; Antihypertensive; Endothelin Receptor Antagonist | Antihypertensives; Other Cardiovascular Products; Muscle Relaxants; Cardiac Therapy | Oral | Tablet | 20-Nov-15 | | 13-Jun-91 | 20-Nov-15 | Pulmonary hypertension (A) | Oral formulation; Small molecule therapeutic | 157212-55-0 | Cardiac failure;Skin ulcer;Scleroderma;Raynauds diseaseulmonary hypertensionulmonary fibrosisulmonary disease;Migraine;Melanoma;Diabetic nephropathy;Cerebrovascular disease |
| cabazitaxel卡巴他赛 | JEVTANA KIT | SANOFI AVENTIS PHR | | Antineoplastics | Parenteral | Injectable | 26-Mar-16 | | 1-Feb-93 | 1-Feb-13 | | Infusion; Small molecule therapeutic; Intravenous formulation | 183133-96-2 | Breast tumor;Stomach tumor;Solid tumor;Ovary tumor;Non-small-cell lung cancer;Lung tumor;Hormone refractory prostate cancer |
| capecitabine卡培他滨 | XELODA | ROCHE | Antineoplastic | Antineoplastics | Oral | Tablet | 14-Dec-13 | | 17-Nov-87 | 13-Jan-11 | Colon cancer, Adjuvant therapy, Duke's Stage C, when treatment with a fluoropyrimidine alone is preferred (A); Metastatic breast cancer, Monotherapy, when resistant to paclitaxel/anthracycline-containing regimens or resistant to paclitaxel and not a candidate for further anthracycline therapy (A); Metastatic breast cancer, In combination with docetaxel after failure of prior anthracycline-containing regimens (A) | Oral formulation; Tablet formulation; Small molecule therapeutic; Prodrug | 154361-50-9 | Breast tumor;Stomach tumor;Solid tumorancreas tumor;Head and neck tumor;Glioma;Colorectal tumor;Colon tumor;Cancer |
| cefditoren pivoxil头孢妥仑匹酯 | SPECTRACEF | ARISTOS PHARM;CORNERSTONE THERAP | Antibacterial (Antibiotic) | Systemic Antibacterials | Oral | Tablet | 14-Oct-16 | | 23-May-02 | | Bronchitis, chronic, Acute bacterial infection (A, P); Tonsillitis (A, P); Pharyngitis (A, P); Infection of skin AND/OR subcutaneous tissue (A, P); Community acquired pneumonia (A, P) | Antibiotic; Small molecule therapeutic; Oral formulation | 117467-28-4 | Bacterial infection;Bacterial skin infection;Bacterial respiratory tract infection;Bacterial pneumonia |
| celecoxib塞来昔布 | CELEBREX | PFIZER | Anti-Inflammatory (Nonsteroidal); Cyclooxygenase-2 Inhibitor; Analgesic | Analgesics; Antineoplastics; Anti-Inflammatory And Anti-Rheumatic Products | Oral | Capsule | 30-May-14 | | 22-Sep-92 | 30-Nov-13 | Ankylosing spondylitis (A); Rheumatoid arthritis (A); Primary dysmenorrhea (A); Pain, acute (A); Osteoarthritis (A); Juvenile rheumatoid arthritis (P); Familial multiple polyposis syndrome (A) | Capsule formulation; Sustained release formulation; Small molecule therapeutic; Parenteral formulation unspecified; Oral formulation; Ophthalmic formulation; Intravenous formulation; Injectable formulation | 169590-42-5 | Alzheimers disease;Uterine cervix tumor;Tenosynovitis;Rheumatoid arthritis;Renal cell carcinomarostate tumoreriarthritisancreas tumor;Pain;Osteoarthritis;Ocular disease;Non-small-cell lung cancer;Non-Hodgkin lymphoma;Keratosis;Gout;Familial adenomatous polyposis;Esophagus tumor;Cachexia;Breast tumor;Bladder tumor;Back pain;Ankylosing spondylitis |
| ciclesonide环索奈德 | OMNARIS | SUNOVION | Glucocorticoid; Antiasthmatic | Anti-Asthma and COPD Products; Systemic Corticosteroids; Nasal Preparations | Inhale;Nasal | Aerosol, Metered;Spray | 24-Oct-17 | | 7-Sep-90 | 9-Jan-13 | Allergic rhinitis (A, P); Asthma (A, P) | Aerosol formulation, dermatological; Transdermal formulation; Steroid; Small molecule therapeutic; Prodrug; Nasal formulation, local; Inhalant formulation; Dermatological formulation; Aerosol formulation, inhalant | 126544-47-6 | Allergic rhinitis;Chronic obstructive pulmonary disease;Asthma |
| cinacalcet hydrochloride西那卡塞 | SENSIPAR | AMGEN INC | Antihyperparathyroid | Thyroid Therapy; Vitamins | Oral | Tablet | 23-Oct-15 | | 23-Aug-91 | 23-Feb-13 | Dialysis procedure - Renal impairment, chronic - Secondary hyperparathyroidism (A); Hypercalcemia - Parathyroid carcinoma (A) | Oral formulation; Tablet formulation; Small molecule therapeutic | 364782-34-3 | Hypercalcemia;Secondary hyperparathyroidism;Hyperparathyroidism |
| colchicine秋水仙碱 | COLCRYS | A-S MEDICATION;XANODYNE PHARMA;WEST WARD;WATSON LABS;VISION PHARM;URL PHARMA;TEVA PHARMACEUTICA;REPACKAGER;QUALITEST PRODUCTS;MFR NOT STATED;MEDVANTX;MAJOR PHARM;EXCELLIUM PHARM;BEDFORD LABS;BALAN,J.J.;AR SCIENTIFIC;AMNEAL PHARM;ALPHAGEN LABS;ABBOTT PHARM PRODS | Antigout; Analgesic | All Other Therapeutic Products; Urologicals; Other Drugs For Disorders Of The Musculo-Skeletal System; Functional Gastro-Intestinal Disorder Drugs; Anti-Inflammatory And Anti-Rheumatic Products; Anti-Gout Preparations; Analgesics | Oral;Parenteral;Other | Injectable;Tablet;Powder | 29-Jul-16 | | 7-May-97 | | Familial Mediterranean fever (A, P); Gout; Prophylaxis (A, P); Gout (A) | Infusion; Tablet formulation; Small molecule therapeutic; Oral formulation; Natural product; Liposome formulation; Intravenous formulation | 64-86-8 | Cancer;Thalassemia;Gout;Familial mediterranean fever |
| colesevelam hydrochloride考来维仑 | WELCHOL | DAIICHI SANKYO INC | Antilipemic; Cardiotonic | Lipid-Regulating/Anti-Atheroma Preparations | Oral | Granule;Tablet | 29-Oct-14 | | 2-Jun-93 | 2-Jun-13 | Diabetes mellitus type 2; Adjunct (A); Primary hypercholesterolemia (A); Familial hypercholesterolemia - heterozygous (P) | Oral formulation; Tablet formulation; Small molecule therapeutic; Oral suspension formulation | 182815-44-7 | Hypercholesterolemia;Non-insulin dependent diabetes |
| darifenacin hydrobromide达非那新 | ENABLEX | WARNER-CHILCOTT | Antispasmodic; Uricosuric; Antimuscarinic | Antidiarrhoeals, Oral Electrolyte Replacers and Intestinal Anti-Inflammatories; Urologicals; Functional Gastro-Intestinal Disorder Drugs | Oral | Tablet, Extended Release | 13-Mar-15 | | 17-Mar-89 | 13-Mar-10 | Bladder muscle dysfunction - overactive (A) | Oral formulation; Tablet formulation; Small molecule therapeutic; Oral sustained release formulation | 133099-07-7 | Irritable bowel syndrome;Urinary incontinence;Overactive bladder |
| decitabine地西他滨 | DACOGEN | EISAI INC | Antineoplastic; Antiviral | Antineoplastics; Antivirals For Systemic Use | Parenteral | Injectable | 2-May-13 | | 24-Jul-98 | | Myelodysplastic syndrome (A) | Infusion; Small molecule therapeutic; Intravenous formulation | 2353-33-5 | Acute lymphoblastic leukemia;Solid tumor;Sickle cell anemia;Renal cell carcinoma;Prostate tumor;Ovary tumor;Non-small-cell lung cancer;Non-Hodgkin lymphoma;Myelodysplastic syndrome;Melanoma;Leukemia;Colon tumor;Chronic myelocytic leukemia;Breast tumor;Acute myelogenous leukemia |
| desvenlafaxine succinate monohydrate琥珀酸去甲文拉法辛 | PRISTIQ | PFIZER | Antidepressant | Psychoanaleptics Excluding Anti-Obesity Preparations | Oral | Tablet, Delayed Release;Tablet, Extended Release | 1-Mar-13 | | 8-Jan-07 | | | | 386750-22-7 | Hot flashes;Neuropathic pain;Myalgia;Major depressive disorder |
| dexmedetomidine hydrochloride右美托咪定 | PRECEDEX | HOSPIRA | Sedative/Hypnotic; Adrenergic Agonist (Alpha-); Anesthetic | Anaesthetics; Psycholeptics | Parenteral | Injectable | 15-Jul-13 | | 7-Aug-79 | 15-Jul-13 | Sedation, Intubated/mechanically ventilated ICU patients (A); Sedation, Non-intubated patients (A) | Buccal formulation, local; Transdermal formulation; Stereochemistry; Small molecule therapeutic; Intravenous formulation; Infusion; Buccal formulation, systemic | 145108-58-3 | Anesthesia;Pain |
| doripenem多尼培南 | DORIBAX | ORTHO PHARM | Antibacterial | Systemic Antibacterials | Parenteral | Injectable | 5-Jun-15 | | 20-Aug-91 | 14-Aug-12 | Infectious disease of abdomen, Complicated (A); Urinary tract infectious disease, Complicated (A); Pyelonephritis (A) | Antibiotic; Small molecule therapeutic; Intravenous formulation; Inhalant formulation; Infusion | 148016-81-3 | Acinetobacter infection;Streptococcus pneumoniae infection;Streptococcus infection;Respiratory tract infection;Pyelonephritis;Pseudomonas aeruginosa infection;Proteus mirabilis infection;Klebsiella pneumoniae infection;Klebsiella infection;Gram positive bacterium infection;Gram negative bacterium infection;Escherichia coli infection;Burkholderia infection;Bacteroides infection;Bacteroides fragilis infection;Bacterial urinary tract infection;Bacterial respiratory tract infection;Bacterial pneumonia;Bacterial infection |
| dronedarone hydrochloride决奈达隆 | MULTAQ | SANOFI AVENTIS PHR | Antiarrhythmic | Cardiac Therapy | Oral | Tablet | 1-Jul-14 | | 6-Aug-90 | 26-Jul-11 | Atrial fibrillation, Paroxysmal or Persistent (A); Atrial flutter, Paroxysmal or persistent (A) | Film coating; Tablet formulation; Small molecule therapeutic; Oral formulation | 141625-93-6 | |
| duloxetine hydrochloride度洛西汀 | CYMBALTA | LILLY | Antidepressant; Serotonin Noradrenaline Reuptake Inhibitor (SNRI) | Other CNS Drugs; Urologicals; Psychoanaleptics Excluding Anti-Obesity Preparations | Oral | Capsule, Delayed Release | 11-Jun-13 | | 22-Dec-86 | 11-Sep-07 | Diabetic peripheral neuropathy - Pain (A); Major depressive disorder (A); Generalized anxiety disorder (A); Fibromyalgia (A) | Capsule formulation; Small molecule therapeutic; Oral formulation | 136434-34-9 | Back pain;Urinary incontinence;Post traumatic stress disorder;Panic disorder;Obsessive compulsive disorder;Neuropathic pain;Musculoskeletal pain;Major depressive disorder;Generalized anxiety disorder;Fibromyalgia;Diabetic neuropathy;Chronic fatigue syndrome |
| dutasteride度他雄胺 | AVODART | GSK PHARM | Antiprostatic Hypertrophy; 5Alpha-Reductase Inhibitor | Urologicals | Oral | Capsule | 20-Nov-15 | | 17-Sep-93 | 17-Sep-13 | Benign prostatic hyperplasia (A) | Capsule formulation; Small molecule therapeutic; Oral formulation | 164656-23-9 | Alopecia;Prostate tumor;Prostate hyperplasia |
efavirenz依非韦伦
| SUSTIVA | DUPONT PHARM | Antiviral; Reverse Transcriptase Inhibitor | Anti-Inflammatory And Anti-Rheumatic Products; Antivirals For Systemic Use | Oral | Capsule;Tablet | 21-May-13 | | 7-Aug-92 | 7-Aug-12 | HIV infection (A, P) | Capsule formulation; Tablet formulation; Small molecule therapeutic; Oral formulation | 154598-52-4 | HIV infection |
| eletriptan hydrobromide依来曲普坦 | RELPAX | PFIZER | Antimigraine; Serotonin Receptor Agonist | Analgesics | Oral | Tablet | 26-Dec-16 | | 15-Oct-90 | 13-Aug-13 | Migraine (A) | Oral formulation; Small molecule therapeutic | 177834-92-3 | Migraine |
| emtricitabine恩曲他滨 | EMTRIVA | GILEAD SCIENCES | Antiviral | Antivirals For Systemic Use | Oral | Capsule;Liquid | 29-Mar-16 | | 1-Feb-90 | 1-Feb-10 | HIV infection (A, P) | Capsule formulation; Stereochemistry; Small molecule therapeutic; Oral formulation | 143491-57-0 | HIV infection;Hepatitis B virus infection;HIV-1 infection |
| entecavir恩替卡韦 | BARACLUDE | BRISTOL-M SQ US PH | Antiviral | Antivirals For Systemic Use | Oral | Liquid;Tablet | 21-Feb-15 | | 18-Oct-90 | 23-Aug-11 | | | 209216-23-9 | |
eptifibatide依非巴特
| INTEGRILIN | SCHERING | Antithrombotic; Antianginal | Antithrombotic Agents; Cardiac Therapy | Parenteral | Injectable | 11-Nov-14 | | 16-Jun-89 | 7-Jun-11 | Acute coronary syndrome (A); Percutaneous coronary intervention (A) | Biological therapeutic; Peptide; Parenteral formulation unspecified; Injectable formulation; Infusion | 148031-34-9 | Angina;Thromboembolism;Myocardial infarction;Coronary artery disease;Cerebrovascular ischemia;Cardiovascular disease |
ertapenem sodium厄他培南钠
| INVANZ | MERCK & COMPANY | Antibacterial (Antibiotic) | Other Anti-Infectives; Systemic Antibacterials | Parenteral | Injectable | 2-Aug-13 | | 4-Feb-92 | 2-Feb-13 | Community acquired pneumonia (A, P); Urinary tract infectious disease, Complicated (A, P); Pelvic infection, acute (A, P); Operation on intestine - Postoperative wound infection; Prophylaxis (A); Infectious disease of abdomen, Complicated (A, P); Infection of skin AND/OR subcutaneous tissue, Complicated (A, P); Diabetic foot infection, without osteomyelitis (A, P) | Antibiotic; Small molecule therapeutic; Intravenous formulation; Intramuscular formulation; Infusion | 153832-38-3 | |
| estradiol acetate雌二醇 | FEMRING | WARNER-CHILCOTT | Estrogen | Sex Hormones And Products With Similar Desired Effects, Systemic Action Only | Oral;Other | Other Special Forms;Tablet | 19-Dec-15 | | | | | | 4245-41-4 | Menopause |
| everolimus依维莫司 | AFINITOR | NOVARTIS RX | Immunosuppressant | Antineoplastics; Immunosuppressants | Oral | Tablet | 30-Mar-14 | | 6-Jun-89 | 24-Sep-13 | Renal cell carcinoma, Advanced disease after failure of treatment with sunitinib or sorafenib (A); Renal transplant rejection; Prophylaxis (A) | Oral formulation; Tablet formulation; Small molecule therapeutic | 159351-69-6 | Age related macular degeneration;Uveitis;Uterine cervix tumor;Tuberous sclerosis;Transplant rejection;Stomach tumor;Solid tumor;Small-cell lung cancer;Rheumatoid arthritis;Renal cell carcinoma;Polycystic kidney disease;Pancreatic endocrine tumor;Pancreas tumor;Non-small-cell lung cancer;Neuroendocrine tumor;Multiple myeloma;Melanoma;Mantle cell lymphoma;Macroglobulinemia;Lymphoma;Lung tumor;Liver transplant rejection;Kidney transplant rejection;Inflammatory bowel disease;Hormone refractory prostate cancer;Hepatocellular carcinoma;Hematological neoplasm;Heart transplant rejection;Head and neck tumor;Genetic disorder;Gastrointestinal stromal tumor;Endometroid carcinoma;Diffuse large B-cell lymphoma;Colorectal tumor;Breast tumor |
| exenatide艾塞那肽 | BYETTA | AMYLIN PHARM | Antidiabetic | Drugs Used In Diabetes | Parenteral | Injectable | 1-Dec-16 | | 24-May-93 | 1-Dec-16 | Diabetes mellitus type 2, In patients taking metformin, a sulfonylurea, a thiazolidinedione, a combination of metformin and a sulfonylurea or a thiazolidinedione, but have not achieved adequate glycemic control; Adjunct (A); Diabetes mellitus type 2, Monotherapy (A) | Biological therapeutic; Transdermal formulation; Sustained release formulation; Suspension; Subcutaneous formulation; Subcutaneous drug implant; Small molecule therapeutic; Protein fusion; Protein conjugated; Peptide; Patch formulation; Oral formulation; Natural product; Nasal systemic formulation; Nanoparticle formulation, oral; Microparticle formulation; Injectable controlled release formulation | 141732-76-5 | Central nervous system disease;Polycystic ovary syndrome;Obesity;Non-insulin dependent diabetes;Insulin dependent diabetes;Diabetes mellitus |
ezetimibe依泽替麦
| ZETIA | MERCK/SCHERING-PLG | Antilipemic | Lipid-Regulating/Anti-Atheroma Preparations | Oral | Tablet | 25-Apr-17 | | 9-Jul-93 | 21-Mar-14 | Familial hypercholesterolemia - homozygous (A, P); Sitosterolemia, Homozygous familial (A, P); Primary hypercholesterolemia (A); Mixed hyperlipidemia (A) | Oral formulation; Tablet formulation; Small molecule therapeutic | 163222-33-1 | Familial hypercholesterolemia;Sitosterolemia;Hypercholesterolemia |
| febuxostat非布索坦 | ULORIC | TAKEDA PHARM USA | Antigout; Xanthine Oxidase Inhibitor | Anti-Gout Preparations | Oral | Tablet | 25-Mar-14 | | 30-Nov-90 | 25-Mar-14 | Gout - Hyperuricemia (A) | Oral formulation; Small molecule therapeutic | 144060-53-7 | Gout |
| follitropin alfa促卵泡素 | GONAL-F | EMD SERONO | Gonad-Stimulating Principle | Sex Hormones And Products With Similar Desired Effects, Systemic Action Only | Parenteral | Injectable | 16-Jun-15 | | 2-Nov-83 | 20-Jun-06 | Female infertility - Reproductive technology management (A); Ovulation induction, In anovulatory patients in whom the cause of infertility is functional and not due to primary ovarian failure (A); Male hypogonadotropic hypogonadism, Primary and secondary, in whom the cause of infertility is not due to primary testicular failure - Spermatogenesis induction (A) | Biological therapeutic; Subcutaneous formulation; Protein recombinant; Peptide | 56832-30-5 | Female infertility;Male infertility;Infertility;Hypogonadism |
| follitropin beta | FOLLISTIM | ORGANON | Gonad-Stimulating Principle | Sex Hormones And Products With Similar Desired Effects, Systemic Action Only | Parenteral | Injectable | 16-Jun-15 | | 2-Nov-83 | 20-Jun-06 | | | 110909-60-9 | Female infertility;Male infertility |
| fosamprenavir calcium福沙那伟钙 | LEXIVA | VIIV HEALTHCARE | Antiviral; HIV Proteinase Inhibitor | Antivirals For Systemic Use; Blood Coagulation System, Other Products | Oral | Suspension;Tablet | 24-Dec-17 | | | | | | 226700-81-8 | |
| frovatriptan succinate琥珀酸福伐曲坦 | FROVA | ENDO LABS | Antimigraine; Serotonin Receptor Agonist | Analgesics | Oral | Tablet | 7-Nov-15 | | 26-Jun-91 | 16-Dec-13 | Migraine (A) | Oral formulation; Tablet formulation; Small molecule therapeutic | 158930-17-7 | Migraine |
| gatifloxacin加替沙星 | ZYMAR | ALLERGAN;BRISTOL-M SQ US PH | Antibacterial (Synthetic) | Ophthalmological/Otological Combinations; Urologicals; Systemic Antibacterials; Ophthalmologicals | Ophthalmic;Parenteral;Oral | Injectable;Tablet;Liquid/Drops | 5-Jun-16 | | 21-Jan-86 | 27-Aug-08 | Bacterial conjunctivitis (A, P); Urinary tract infectious disease (A); Sinusitis, acute (A); Pyelonephritis (A); Infection of skin AND/OR subcutaneous tissue, uncomplicated (A); Gonorrhea (A); Community acquired pneumonia, Including multi-drug resistant S pneumoniae (A); Bronchitis, chronic, Acute bacterial exacerbation (A) | Antibiotic; Solution; Small molecule therapeutic; Oral formulation; Ophthalmic liquid formulation; Ophthalmic formulation; Intravenous formulation | 112811-59-3 | Bacterial infection;Streptococcus pneumoniae infection;Streptococcus infection;Staphylococcus infection;Staphylococcus aureus infection;Haemophilus influenzae infection;Corynebacterium infection;Conjunctivitis |
| gefitinib吉非替尼 | IRESSA | ASTRAZENECA | Antineoplastic | Antineoplastics | Oral | Tablet | 19-Jan-13 | | 20-Jan-92 | 19-Jan-13 | Non-small cell lung cancer, Continued monotherapy in patients with locally advanced/metastatic NSCLC who have failed both platinum and docetaxel-based chemotherapies, or in patients who are or have benefited from gefitinib (A) | Infusion; Tablet formulation; Small molecule therapeutic; Oral formulation; Nanoparticle formulation, injectable; Liposome formulation, injectable; Intravenous formulation | 184475-35-2 | Bladder tumor;Uterine cervix tumor;Stomach tumor;Solid tumor;Sarcoma;Renal cell carcinoma;Pancreas tumor;Ovary tumor;Non-small-cell lung cancer;Nasopharynx tumor;Mesothelioma;Melanoma;Liver tumor;Hormone refractory prostate cancer;Head and neck tumor;Glioma;Esophagus tumor;Colorectal tumor;Carcinoma;Cancer;Breast tumor;Brain tumor |
| glatiramer acetate格拉替雷 | COPAXONE | TEVA NEUROSCIENCE | Immunomodulator; Neuroprotective | Immunostimulating Agents; Other CNS Drugs | Parenteral | Injectable | 24-May-14 | | 21-Apr-71 | 24-May-14 | Relapsing remitting multiple sclerosis (A) | Biological therapeutic; Subcutaneous formulation; Small molecule therapeutic; Peptide; Oral formulation | 147245-92-9 | Crohns disease;Optic neuritis;Neurodegenerative disease;Multiple sclerosis;Motor neurone disease;Huntingtons chorea;Glaucoma |
| ibuprofen lysine布洛芬赖氨酸盐 | NEOPROFEN | LUNDBECK PHARM | Anti-Inflammatory (Nonsteroidal); Analgesic | Analgesics; Topical Anti-Rheumatics; Other Gynaecologicals; Other Cardiovascular Products; Anti-Inflammatory And Anti-Rheumatic Products | Parenteral | Injectable | 13-Apr-13 | | | | | | 57469-77-9 | |
| imatinib mesylate伊马替尼 | GLEEVEC | NOVARTIS RX | Antineoplastic | Antineoplastics; Psycholeptics | Oral | Capsule;Tablet | 4-Jul-15 | | 3-Apr-92 | 15-Sep-14 | Acute lymphoid leukemia, Relapsed/Refractory Philadelphia chromosome-positive (A); Systemic mast cell disease, Aggressive (A); Myeloproliferative disorder, chronic, With PDGFR (platelet-derived growth factor receptor) gene rearrangement (A); Myelodysplastic syndrome, With PDGFR (platelet-derived growth factor receptor) gene rearrangement (A); Hypereosinophilic syndrome (A); Gastrointestinal stromal tumor (A); Dermatofibrosarcoma protuberans, Unresectable, recurrent and/or metastatic (A); Chronic phase chronic myeloid leukemia, Philadelphia chromosome-positive, recurrence after stem cell transplant (P); Chronic phase chronic myeloid leukemia, Philadelphia chromosome-positive, newly diagnosed (A, P); Chronic phase chronic myeloid leukemia, Philadelphia chromosome-positive, after failure of interferon-alpha therapy (A, P); Chronic myeloid leukemia, Philadelphia chromosome-positive, accelerated phase or blast crisis (A); Chronic eosinophilic leukemia (A) | Oral formulation; Tablet formulation; Small molecule therapeutic | 220127-57-11 | Acute lymphoblastic leukemia;Thyroid tumor;Solid tumor;Sarcoma;Rheumatoid arthritis;Renal cell carcinoma;Pulmonary hypertension;Pulmonary fibrosis;Prostate tumor;Myeloproliferative disorder;Myeloid leukemia;Myelodysplastic syndrome;Melanoma;Mastocytosis;Lung tumor;Intestine tumor;Hypereosinophilic syndrome;Hormone refractory prostate cancer;Glioma;Gastrointestinal tumor;Gastrointestinal stromal tumor;Dermatofibrosarcoma;Chronic myelocytic leukemia;Cancer;Bone marrow transplantation;Acute myelogenous leukemia |
| imiglucerase伊米苷酶 | CEREDASE | GENZYME CORP | | All Other Therapeutic Products | Parenteral | Injectable | 27-Aug-13 | | 23-Dec-88 | 17-Aug-10 | Non-neuropathic Gaucher's disease, chronic, symptomatic (A, P) | Biological therapeutic; Small molecule therapeutic; Protein recombinant; Intravenous formulation; Infusion; Enzyme; DNA technology | 154248-97-2 | Gaucher disease;Gauchers disease type III;Gauchers disease type I |
| insulin aspart门冬胰岛素 | NOVOLOG | NOVO NORDISK | Antidiabetic | Drugs Used In Diabetes | Parenteral | Injectable | 7-Dec-14 | | 25-Feb-81 | 7-Dec-14 | Diabetes mellitus type 1 (A, P); Diabetes mellitus type 2 (A) | Biological therapeutic; Subcutaneous formulation; Solution; Quick release formulation; Protein recombinant; Intravenous formulation | 116094-23-6 | Diabetes mellitus;Non-insulin dependent diabetes;Insulin dependent diabetes |
| insulin detemir地特胰岛素 | LEVEMIR | NOVO NORDISK | Antidiabetic | Drugs Used In Diabetes | Parenteral | Injectable | 2-Feb-14 | | 17-Sep-93 | 2-Feb-14 | Diabetes mellitus type 1 (A, P); Diabetes mellitus type 2 (A) | Biological therapeutic; Subcutaneous formulation; Peptide; Injectable controlled release formulation | 169148-63-4 | Diabetes mellitus |
| insulin glargine甘精胰岛素 | LANTUS | SANOFI AVENTIS PHR | Antidiabetic | Drugs Used In Diabetes | Parenteral | Injectable | 12-Feb-15 | | 12-Mar-85 | 6-May-10 | Diabetes mellitus type 1 (A, P); Diabetes mellitus type 2 (A) | Biological therapeutic; Subcutaneous formulation; Protein recombinant | 160337-95-1 | Diabetes mellitus;Non-insulin dependent diabetes;Insulin dependent diabetes |
| insulin lispro recombinant赖脯胰岛素 | HUMALOG | LILLY | Antidiabetic | Drugs Used In Diabetes | Parenteral | Injectable | 7-May-13 | | 9-Feb-89 | 7-May-13 | Diabetes mellitus type 1 (A, P); Diabetes mellitus type 2 (A, P) | Biological therapeutic; Subcutaneous formulation; Peptide; Intravenous formulation; Infusion; DNA technology | 133107-64-9 | Diabetes mellitus |
| lacosamide拉科酰胺 | VIMPAT | SCHWARZ PHARMA | Anticonvulsant; Analgesic | Analgesics; Anti-Epileptics | Oral;Parenteral | Injectable;Tablet;Liquid | 5-Aug-14 | | 15-Feb-85 | 3-Jan-12 | Partial seizure; Adjunct (A) | Infusion; Tablet formulation; Solution; Small molecule therapeutic; Oral liquid formulation; Oral formulation; Intravenous formulation | 175481-36-4 | Epilepsy;Osteoarthritis;Neuropathic pain;Migraine;Fibromyalgia |
| lanreotide acetate兰瑞肽 | SOMATULINE DEPOT | TERCICA, INC | Antineoplastic (Hormonal); Somatostatin Analog | Cardiac Therapy; Pituitary And Hypothalamic Hormones; Ophthalmologicals; Nonsteroidal Products for Inflammatory Skin Disorders; Cytostatic Hormone Therapy | Parenteral | Injectable | 30-Aug-14 | | 12-Sep-85 | | Acromegaly (A) | Biological therapeutic; Sustained release formulation; Solution; Peptide; Parenteral formulation unspecified; Injectable formulation | 127984-74-1 | Acromegaly;Restenosis;Renal tumor;Prostate tumor;Pancreatitis;Pancreas tumor;Neuroendocrine tumor;Hypertension;Esophageal disease;Diarrhea;Carcinoid syndrome;Breast tumor |
| lenalidomide来那度胺 | REVLIMID | CELGENE | Immunomodulator | Antineoplastic And Immunomodulating Agents; Immunosuppressants | Oral | Capsule | 24-Jul-16 | | 24-Jul-96 | 24-Jul-16 | Multiple myeloma, in combination with dexamethasone, in patients who have received at least 1 prior therapy (A); Myelodysplastic syndrome, Transfusion-dependent, deletion 5q abnormality, low or intermediate-1 risk (A) | Capsule formulation; Small molecule therapeutic; Oral formulation | 191732-72-6 | Acute myelogenous leukemia;Solid tumor;Renal cell carcinoma;Peripheral T-cell lymphoma;Pancreas tumor;Non-Hodgkin lymphoma;Myelodysplastic syndrome;Multiple myeloma;Melanoma;Mantle cell lymphoma;Macroglobulinemia;Kaposis sarcoma;Inflammatory disease;Hormone refractory prostate cancer;Hodgkins disease;Head and neck tumor;Glioblastoma;Diffuse large B-cell lymphoma;Cutaneous T-cell lymphoma;Crohns disease;Complex regional pain syndrome;Colorectal tumor;Chronic lymphocytic leukemia;Cardiac failure;Cancer;B-cell acute lymphoblastic leukemia;Amyloidosis;Adult T-cell lymphoma |
| levoleucovorin calcium左旋亚叶酸钙 | FUSILEV | SPECTRUM PHARM | Antiemetic; Antineoplastic Adjunct | All Other Therapeutic Products; Antineoplastics; Anti-Anaemic Preparations | Parenteral | Injectable | 7-Mar-15 | | 3-Sep-86 | | Antimetabolite overdose, Folic acid antagonist (A, P); Levoleucovorin rescue, After high dose methotrexate for osteosarcoma (A, P) | Injectable formulation; Tablet formulation; Small molecule therapeutic; Parenteral formulation unspecified; Oral formulation | 80433-71-2 | Anemia;Osteosarcoma;Colon tumor;Cancer;Bladder tumor |
| linezolid利奈唑胺 | ZYVOX | PFIZER | Antibacterial (Synthetic) | Analgesics; Systemic Antibacterials | Oral;Parenteral | Injectable;Tablet;Suspension | 18-May-15 | | 9-Sep-93 | 9-Sep-13 | Community acquired pneumonia (A, P); Vancomycin-resistant Enterococcus faecium infection (A, P); Nosocomial pneumonia (A, P); Infection of skin AND/OR subcutaneous tissue, uncomplicated (A, P); Infection of skin AND/OR subcutaneous tissue, Complicated (A, P) | Antibiotic; Tablet formulation; Small molecule therapeutic; Oral suspension formulation; Oral formulation; Intravenous formulation; Infusion; Granule | 165800-03-3 | Bacterial infection;Streptococcus pyogenes infection;Streptococcus pneumoniae infection;Streptococcus agalactiae infection;Staphylococcus aureus infection;Sepsis;Osteomyelitis;Multidrug resistant infection;MRSA infection;Gram positive bacterium infection;Enterococcus faecium infection;Diabetic foot ulcer;Bacterial skin infection;Bacterial pneumonia |
| liraglutide利拉鲁肽 | VICTOZA | NOVO NORDISK | Antidiabetic | Drugs Used In Diabetes | Parenteral | Injectable | 22-Aug-17 | | 5-May-86 | 5-Feb-16 | | Biological therapeutic; Weekly dosing; Sustained release formulation; Subcutaneous formulation; Solution; Protein recombinant | 204656-20-2 | Non-alcoholic steatohepatitis;Obesity;Non-insulin dependent diabetes |
| lubiprostone鲁比前列酮 | AMITIZA | TAKEDA PHARM USA | Laxative/Cathartic | Laxatives | Oral | Capsule | 14-Jul-14 | | 28-Jan-87 | 28-Jan-08 | Constipation - Irritable bowel syndrome (A); Idiopathic constipation, chronic (A) | Capsule formulation; Small molecule therapeutic; Oral formulation | 136790-76-6 | Constipation;Irritable bowel syndrome;Ileus |
| moxifloxacin hydrochloride莫西沙星 | AVELOX | ALCON OPHTHALMICS;SCHERING | Antibacterial | Ophthalmologicals; Systemic Antibacterials | Ophthalmic;Parenteral;Oral | Injectable;Tablet;Liquid/Drops | 4-Mar-14 | | 15-Jul-88 | 30-Jun-09 | Acute infective exacerbation of chronic obstructive pulmonary disease (A); Infectious disease of abdomen, Complicated (A); Infection of skin AND/OR subcutaneous tissue, uncomplicated (A); Infection of skin AND/OR subcutaneous tissue, Complicated (A); Community acquired pneumonia (A); Bacterial sinusitis, acute (A); Bacterial conjunctivitis (A, P) | Antibiotic; Tablet formulation; Small molecule therapeutic; Oral formulation; Ophthalmic liquid formulation; Ophthalmic formulation; Intravenous formulation; Infusion; Film coating | 186826-86-8 | Abdominal abscess;Streptococcus pyogenes infection;Streptococcus pneumoniae infection;Streptococcus infection;Staphylococcus infection;Staphylococcus aureus infection;Salpingitis;Proteus mirabilis infection;Pelvic inflammatory disease;Mycoplasma infection;Mycobacterium tuberculosis infection;Multidrug resistant infection;Moraxella catarrhalis infection;Micrococcaceae infection;Klebsiella pneumoniae infection;Haemophilus influenzae infection;Haemophilus infection;Gram positive bacterium infection;Escherichia coli infection;Enterococcus faecalis infection;Enterobacter infection;Corynebacterium infection;Conjunctivitis;Clostridium infection;Clostridiaceae infection;Chlamydia trachomatis infection;Chlamydia pneumoniae infection;Bronchitis;Bacteroides infection;Bacteroides fragilis infection;Bacterial skin infection;Bacterial respiratory tract infection;Bacterial pneumonia;Bacterial infection;Acute sinusitis;Acute bronchitis;Acinetobacter infection |
| mycophenolate mofetil hydrochloride麦考酚酸酯 | CELLCEPT | ENDO GENERIC PROD;ROCHE | Immunosuppressant; Anti-Inflammatory (Biological Response Modifier) | Anti-Asthma and COPD Products; Urologicals; Immunosuppressants; Cardiac Therapy; Anti-Inflammatory And Anti-Rheumatic Products | Oral;Parenteral | Capsule;Injectable | 15-Sep-13 | | 30-Jan-87 | 30-Jan-07 | Cardiac transplant rejection; Prophylaxis (A); Renal transplant rejection; Prophylaxis (A, P); Liver transplant rejection; Prophylaxis (A) | Oral formulation; Small molecule therapeutic | 116680-01-4 | Autoimmune disease;Transplant rejection;Thrombocytopenia;Rheumatoid arthritis;Restenosis;Respiratory syncytial virus infection;Pemphigus;Myasthenia gravis;Multiple sclerosis;Lupus nephritis;Lung transplant rejection;Liver transplant rejection;Kidney transplant rejection;Inflammatory bowel disease;Heart transplant rejection;Crohns disease |
| mycophenolic acid麦考酚酸 | MYFORTIC | NOVARTIS RX | Antineoplastic; Immunosuppressant; IMPDH Inhibitor | Antineoplastic And Immunomodulating Agents; Immunosuppressants | Oral | Tablet;Tablet, Delayed Release | 10-Apr-17 | | 30-Jan-87 | | | Enteric coated formulation; Tablet formulation; Small molecule therapeutic; Oral formulation | 24280-93-1 | Transplant rejection;Uveitis |
| naltrexone纳曲酮 | VIVITROL | ALKERMES INC | Alcohol Dependence Treatment; Narcotic Antagonist | All Other Therapeutic Products; Other CNS Drugs | Parenteral | Injectable | 2-May-17 | | 9-Oct-84 | 14-May-16 | Alcohol dependence (A); Opioid dependence (A); Alcohol dependence, maintenance of abstinence (A) | Intramuscular formulation; Transdermal formulation; Sustained release formulation; Subcutaneous drug implant; Small molecule therapeutic; Patch formulation; Microparticle formulation; Microcapsule formulation | 16590-41-3 | Alcoholism;Opiate dependence;Irritable bowel syndrome;Drug dependence;Amphetamine dependence |
| olmesartan medoxomil奥美沙坦酯 | BENICAR | DAIICHI SANKYO INC | Antihypertensive; Angiotensin II Receptor Antagonist | Agents Acting On The Renin-Angiotensin System; Antihypertensives; Anti-Inflammatory And Anti-Rheumatic Products | Oral | Tablet | 25-Oct-16 | | 9-Oct-86 | 8-Jul-14 | Hypertension (A, P) | Ophthalmic formulation; Tablet formulation; Small molecule therapeutic; Oral formulation | 144689-63-4 | Diabetic nephropathy;Microalbuminuria;Hypertension;Glomerulonephritis |
| oseltamivir phosphate磷酸奥司他韦 | TAMIFLU | ROCHE | Antiviral; Neuraminidase Inhibitor | Antivirals For Systemic Use; Cough And Cold Preparations | Oral | Capsule;Suspension | 27-Aug-15 | | 27-Feb-95 | 27-Feb-15 | Influenza, Virus types A and B (A, P); Influenza, Virus types A and B; Prophylaxis (A, P) | Capsule formulation; Small molecule therapeutic; Oral formulation; Intravenous formulation | 204255-11-8 | Influenza virus infection |
| paliperidone palmitate棕榈酸帕潘立酮 | INVEGA SUSTENNA | JANSSEN PHARM | Antipsychotic | Psycholeptics | Parenteral | Injectable | 31-Jan-13 | | 7-Nov-88 | 19-Oct-10 | | | 199739-10-1 | |
| palonosetron hydrochloride帕洛诺司琼 | ALOXI | EISAI INC | Antiemetic; Serotonin Receptor Antagonist | | Parenteral | Injectable | 13-Apr-15 | | 28-Nov-89 | 13-Apr-15 | Chemotherapy-induced nausea and vomiting, Acute, associated with highly emetogenic chemotherapy; Prophylaxis (A); Postoperative nausea and vomiting; Prophylaxis (A); Chemotherapy-induced nausea and vomiting, Delayed, associated with moderately emetogenic chemotherapy; Prophylaxis (A); Chemotherapy-induced nausea and vomiting, Acute, associated with moderately emetogenic chemotherapy; Prophylaxis (A) | Capsule formulation; Small molecule therapeutic; Oral formulation; Intravenous formulation; Drug combination | 135729-62-3 | Chemotherapy-induced emesis;Nausea;Emesis |
| pancrelipase胰脂肪酶 | COTAZYM | AXCAN SCANDIPHARM;X-GEN PHARM INC;WATSON LABS;URL PHARMA;TEVA PHARMACEUTICA;SAVAGE LABS;QUALITEST PRODUCTS;PECOS PHARM;MUTUAL PHARM;MCNEIL PHARM;MAJOR PHARM;GLOBAL PHARM CORP;EXPERT MED INC;EURAND PHARM;ETHEX CORP;ECONOLAB;CONTRACT PHARM | Diagnostic Aid (Radiopaque Medium); Enzyme (Digestive); Digestive Aid | All Other Therapeutic Products; Digestives, Including Digestive Enzymes; Diagnostic Imaging | Oral | Capsule;Tablet, Extended Release;Tablet;Capsule, Delayed Release | 30-Apr-14 | | 28-Jul-08 | | Pancreatic insufficiency (A, P) | Biological therapeutic; Oral formulation; Natural product; Microcapsule formulation; Enzyme; Enteric coated formulation; Capsule formulation | 53608-75-6 | Exocrine pancreatic insufficiency;Pancreas disease |
| paricalcitol帕立骨化醇 | ZEMPLAR | ABBOTT PHARM PRODS | Antiosteoporotic; Antihyperparathyroid | Other Drugs For Disorders Of The Musculo-Skeletal System; Vitamins; Thyroid Therapy | Oral;Parenteral | Capsule;Injectable | 24-Jun-14 | | 9-Mar-89 | 9-Mar-09 | Renal impairment, chronic - Secondary hyperparathyroidism; Treatment and Prophylaxis (A, P) | Capsule formulation; Small molecule therapeutic; Oral formulation; Intravenous formulation | 131918-61-1 | Hyperparathyroidism;Secondary hyperparathyroidism |
| paroxetine mesylate甲磺酸帕罗西汀 | PEXEVA | NOVEN PHARM | Antidepressant; Serotonin Uptake Inhibitor; Antiobsessional | Psychoanaleptics Excluding Anti-Obesity Preparations; Psycholeptics | Oral | Tablet | 10-Jun-17 | | | | | | 217797-14-3 | Generalized anxiety disorder;Panic disorder;Obsessive compulsive disorder;Major depressive disorder;Hot flashes |
| pemetrexed disodium培美曲塞 | ALIMTA | LILLY | Antineoplastic | Antineoplastic And Immunomodulating Agents; Antineoplastics | Parenteral | Injectable | 24-Jan-17 | | 2-Jul-99 | | Malignant mesothelioma of pleura, In combination with cisplatin in patients who are not candidates for surgical resection (A); Non-small cell lung cancer, Nonsquamous, Locally advanced or metastatic (A) | Infusion; Small molecule therapeutic; Intravenous formulation | 150399-23-8 | Acute lymphoblastic leukemia;Urinary tract tumor;Stomach tumor;Solid tumor;Small-cell lung cancer;Pancreas tumor;Ovary tumor;Osteosarcoma;Non-small-cell lung cancer;Mesothelioma;Head and neck tumor;Gastrointestinal tumor;Gallbladder tumor;Colorectal tumor;Breast tumor;Biliary cancer;Acute myelogenous leukemia |
| pimecrolimus吡美莫司 | ELIDEL | NOVARTIS RX | Antibacterial (Antibiotic); Immunosuppressant | Nonsteroidal Products for Inflammatory Skin Disorders; Systemic Antibacterials | Topical | Cream | 15-Dec-16 | | 9-Nov-89 | 4-Oct-11 | Atopic dermatitis, Second-line therapy (A, P) | Dermatological formulation; Tablet formulation; Small molecule therapeutic; Ophthalmic liquid formulation; Emulsion, dermatological | 137071-32-0 | Asthma;Rheumatoid arthritis;Psoriasis;Ocular disease;Inflammatory bowel disease;Erythematosquamous skin disease;Dermatitis;Contact dermatitis;Atopic dermatitis |
| pitavastatin calcium匹伐他汀钙 | LIVALO | LILLY | Antilipemic; HMG CoA Reductase Inhibitor | Lipid-Regulating/Anti-Atheroma Preparations | Oral | Tablet | 29-Dec-15 | | 20-Aug-87 | 19-Aug-08 | Hyperlipidemia (A) | Oral formulation; Tablet formulation; Small molecule therapeutic | | |
| posaconazole泊沙康唑 | NOXAFIL | SCHERING | Antifungal (Synthetic) | Antiprotozoals and Anthelmintics; Systemic Agents For Fungal Infections; Stomatologicals, Mouth Preparations, Medicinal Dentifrices Etc | Oral | Suspension | 26-Aug-14 | | 21-Dec-93 | 2-Dec-14 | Aspergillosis, Invasive, in high-risk patients; Prophylaxis (A, P); Oropharyngeal candidiasis (A); HIV infection - Oropharyngeal candidiasis (A); Disseminated candidiasis, Severely immunocompromised patients; Prophylaxis (A, P) | Intravenous formulation; Small molecule therapeutic; Oral suspension formulation; Oral formulation | 171228-49-2 | Aspergillus infection;Trypanosoma cruzi infection;Prophylaxis;Onychomycosis;Fusarium infection;Fungal infection;Coccidioides infection;Chromoblastomycosis;Candida infection |
| prasugrel hydrochloride普拉格雷 | EFFIENT | LILLY | | Antithrombotic Agents | Oral | Tablet | 10-Jul-14 | | | | | | 389574-19-0 | |
| prednisolone acetate醋酸泼尼松 | ECONOPRED | A-A SPECTRUM;WATSON LABS;TEVA PHARMACEUTICA;TARO PHARM;STERIS LABORATORIE;REPACKAGER;PRIVATE LABEL;PACIFIC PHARM;MFR NOT STATED;MEDISCA INC;MAJOR PHARM;LANNETT;HAWKINS CHEM INC.;FALCON PHARM;DEXO US;ALLERGAN;ALCON OPHTHALMICS;ACTAVIS;A-S MEDICATION | Glucocorticoid | All Other Therapeutic Products; Topical Corticosteroids; Systemic Corticosteroids; Stomatologicals, Mouth Preparations, Medicinal Dentifrices Etc; Ophthalmologicals; Ophthalmological/Otological Combinations; Antivaricosis/Antihaemorrhoidal Preparations; Antifungals, Dermatological; Antidiarrhoeals, Oral Electrolyte Replacers and Intestinal Anti-Inflammatories | Ophthalmic;Parenteral;Other;Oral | Injectable;Tablet;Suspension;Powder;Liquid/Drops;Liquid | 11-Mar-13 | | 4-Aug-05 | | | | 52-21-1 | Allergy;Inflammatory disease;Dermatological disease;Asthma |
| rabeprazole sodium雷贝拉唑钠 | ACIPHEX | EISAI INC | Antiulcerative; Gastric Proton Pump Inhibitor | Antacids, Antiflatulents and Anti-Ulcerants; Systemic Antibacterials | Oral | Tablet, Delayed Release | 8-May-13 | | 13-Nov-86 | 10-Nov-07 | Duodenal ulcer disease (A); Gastroesophageal reflux disease, Symptom control (A, P); Gastroesophageal reflux disease, Erosive or ulcerative, treatment (A); Gastroesophageal reflux disease, Erosive or ulcerative, maintenance (A); Gastric hypersecretion (A); Duodenal ulcer disease, Triple therapy - Helicobacter pylori gastrointestinal tract infection (A) | Capsule formulation; Tablet formulation; Sustained release formulation; Small molecule therapeutic; Oral formulation | 117976-90-6 | Dyspepsia;Zollinger-Ellison syndrome;Peptic ulcer;Helicobacter pylori infection;Gastrointestinal ulcer;Gastroesophageal reflux |
| rasagiline mesylate甲磺酸雷沙吉兰 | AZILECT | TEVA NEUROSCIENCE | Antiparkinsonian | Anti-Parkinson Drugs | Oral | Tablet | 7-Feb-17 | | 3-Jan-90 | 21-Dec-10 | Parkinson's disease, Initial monotherapy (A); Parkinson's disease, To levodopa; Adjunct (A) | Oral formulation; Tablet formulation; Small molecule therapeutic | 161735-79-1 | Alzheimers disease;Restless legs syndrome;Progressive supranuclear palsy;Parkinsons disease |
| ritonavir.利托那韦 | NORVIR | ABBOTT PHARM PRODS | Antiviral; HIV Proteinase Inhibitor; Retroviral Protease Inhibitor | Antivirals For Systemic Use; Blood Coagulation System, Other Products | Oral | Capsule;Tablet;Liquid | 30-Jan-14 | | 23-May-89 | 23-May-09 | HIV infection (A, P) | Capsule formulation; Tablet formulation; Small molecule therapeutic; Peptidomimetic; Oral liquid formulation; Oral formulation | 155213-67-5 | HIV infection |
| rosuvastatin calcium瑞舒伐他汀 | CRESTOR | ASTRAZENECA | Antilipemic; HMG CoA Reductase Inhibitor | Lipid-Regulating/Anti-Atheroma Preparations | Oral | Tablet | 8-Jul-16 | | 1-Jul-91 | 12-Jun-12 | Disorder of cardiovascular system, Primary; Prophylaxis (A); Mixed hyperlipidemia (A); Hypertriglyceridemia (A); Hyperlipidemia, Primary (A, P); Generalized atherosclerosis (A); Familial type 3 hyperlipoproteinemia (A); Familial hypercholesterolemia - homozygous (A) | Oral formulation; Tablet formulation; Small molecule therapeutic | 147098-20-2 | Aortic stenosis;Renal disease;Myocardial infarction;Hyperlipidemia;Hypercholesterolemia;Familial hypercholesterolemia;Congestive heart failure;Cerebrovascular ischemia;Atherosclerosis |
| sevelamer carbonate碳酸司维拉姆 | RENVELA | GENZYME CORP | Antihyperphosphatemic | All Other Therapeutic Products | Oral | Powder;Tablet | 11-Aug-13 | | 11-Aug-93 | 11-Aug-13 | | Oral formulation; Tablet formulation; Small molecule therapeutic; Oral suspension formulation | 845273-93-0 | Hyperphosphatemia;Renal disease |
| sevelamer hydrochloride司维拉姆 | RENAGEL | GENZYME CORP | Antihyperphosphatemic | All Other Therapeutic Products | Oral | Capsule;Tablet | 16-Sep-14 | | | | End stage renal disease - Hemodialysis - Hyperphosphatemia (A) | Oral formulation; Tablet formulation; Small molecule therapeutic | 182683-007 | Hyperphosphatemia;Renal disease |
| sinecatechins赛儿茶素 | VEREGEN | C.C.A. INDUSTRIES;TEVA PHARMACEUTICA;PRIVATE LABEL;PHARMAVITE;PHARMASSURE;PHARMANEX, INC.;NATIONAL VITAMIN C;CHATTEM CONS PROD | Antiviral | All Other Therapeutic Products; Vitamins; Urologicals; Tonics; Other Gynaecologicals; Other Dermatological Preparations; Lipid-Regulating/Anti-Atheroma Preparations; Laxatives; Emollients, Protectives; Dietetic Agents; Antivirals For Systemic Use; Antivaricosis/Antihaemorrhoidal Preparations; Antithrombotic Agents; Antiobesity Preparations, Excluding Dietetics; Antidiarrhoeals, Oral Electrolyte Replacers and Intestinal Anti-Inflammatories; Antacids, Antiflatulents and Anti-Ulcerants | Oral | Capsule;Tablet;Gum, Chewing;Granule | 10-Apr-17 | | | | | | 811420-59-4 | Basal cell carcinoma;Prostatic intraepithelial neoplasia;Prostate tumor;Papillomavirus infection;Keratosis;Condyloma;Chronic lymphocytic leukemia;Cancer;Bladder cancer |
tadalafil他达拉非
| CIALIS | LILLY | Phosphodiesterase Inhibitor; Impotence Therapy | Other Cardiovascular Products; Urologicals | Oral | Tablet | 21-Nov-17 | | 21-Jan-94 | 16-Jul-16 | Erectile dysfunction (A); Pulmonary hypertension (A) | Oral formulation; Transmucosal formulation; Tablet formulation; Small molecule therapeutic; Oral quick release formulation | 171596-29-5 | Angina;Pulmonary hypertension;Prostate hyperplasia;Male sexual dysfunction;Hypertension;Female sexual dysfunction;Erectile dysfunction;Diabetic complication;Cardiac failure |
| telmisartan替米沙坦 | MICARDIS | BOEHRINGER INGEL | Antihypertensive; Angiotensin II Receptor Antagonist | Agents Acting On The Renin-Angiotensin System; Antihypertensives | Oral | Tablet | 7-Jan-14 | | 6-Feb-91 | 7-Jan-14 | Cardiovascular event risk, Reduction (A); Hypertension (A) | Nanoparticle formulation, oral; Tablet formulation; Small molecule therapeutic; Oral formulation | 144701-48-4 | Cerebrovascular ischemia;Syndrome X;Polycystic kidney disease;Obesity;Hypertension;Diabetic nephropathy |
| temsirolimus西罗莫司脂化物 | TORISEL | PFIZER | Antineoplastic | Antineoplastic And Immunomodulating Agents; Antineoplastics | Parenteral | Injectable | 30-May-14 | | 18-Apr-94 | 18-Apr-14 | Renal cell carcinoma, Advanced (A) | Intravenous formulation; Small molecule therapeutic | 162635-04-3 | Breast tumor;Solid tumor;Sarcoma;Rheumatoid arthritis;Renal cell carcinoma;Prostate tumor;Multiple sclerosis;Multiple myeloma;Melanoma;Mantle cell lymphoma;Leukemia;Head and neck tumor;Glioma;Cancer |
| tenofovir disoproxil fumarate富马酸泰诺福韦酯 | VIREAD | GILEAD SCIENCES | Reverse Transcriptase Inhibitor | Antivirals For Systemic Use | Oral | Tablet | 25-Jul-17 | | 25-Apr-85 | 25-Apr-06 | HIV infection (A, P); Type B viral hepatitis, chronic (A) | Dermatological formulation; Vaginal gel formulation; Vaginal formulation; Tablet formulation; Sustained release formulation; Small molecule therapeutic; Rectal gel formulation; Prodrug; Oral formulation; Nucleotide and derivatives; Intravenous formulation; Drug combination; Dermatological gel formulation | 202138-50-9 | HIV infection;Unclassified virus infection;Hepatitis B virus infection;HIV-1 infection |
| thyrotropin alfa促甲状腺激素 | THYROGEN | GENZYME CORP | Thyroid Hormone | Diagnostic Imaging; Thyroid Therapy; Diagnostic Tests | Parenteral | Injectable | 24-Nov-15 | | 2-Nov-83 | 11-Dec-05 | | Biological therapeutic; Protein recombinant; Intramuscular formulation; Controlled release formulation | 194100-83-9 | Nodular goiter;Thyroid tumor |
| tigecycline替加环素 | TYGACIL | PFIZER | Antibacterial (Antibiotic) | Systemic Antibacterials | Parenteral | Injectable | 25-Jun-13 | | 4-Oct-91 | 27-Feb-13 | Community acquired pneumonia (A); Infectious disease of abdomen, Complicated (A); Infection of skin AND/OR subcutaneous tissue, Complicated (A) | Antibiotic; Small molecule therapeutic; Intravenous formulation; Infusion | 220620-09-7 | Bacterial infection;Streptococcus pyogenes infection;Streptococcus pneumoniae infection;Streptococcus infection;Streptococcus agalactiae infection;Staphylococcus aureus infection;MRSA infection;Legionella pneumophila infection;Klebsiella pneumoniae infection;Klebsiella infection;Haemophilus influenzae infection;Escherichia coli infection;Enterococcus faecalis infection;Enterobacter infection;Diabetic foot ulcer;Clostridium infection;Clostridiaceae infection;Citrobacter infection;Bacteroides infection;Bacteroides fragilis infection;Bacterial skin infection;Bacterial pneumonia |
| travoprost曲伏前列腺素 | TRAVATAN | ALCON OPHTHALMICS | Antiglaucoma | Ophthalmologicals | Ophthalmic | Liquid/Drops | 2-Dec-14 | | 3-Aug-93 | 3-Aug-13 | Raised intraocular pressure, In patients with open-angle glaucoma or ocular hypertension (A) | Ophthalmic formulation; Small molecule therapeutic | 157283-68-6 | Glaucoma;Ocular hypertension |
| trimethoprim hydrochloride甲氧苄氨嘧啶 | PRIMSOL | FSC LABORATORIES I | Antibacterial (Synthetic) | Systemic Antibacterials | Oral | Liquid | 7-Aug-16 | | 8-Oct-91 | | Otitis media (P); Urinary tract infectious disease, Uncomplicated (A) | Oral formulation; Small molecule therapeutic | | |
| valganciclovir hydrochloride缬更昔洛韦 | VALCYTE | ROCHE | Antiviral | Antivirals For Systemic Use | Oral | Suspension;Tablet | 29-Sep-15 | | 19-Dec-88 | 18-Dec-09 | AIDS - Cytomegaloviral retinitis (A); Cytomegalovirus infection, in high risk kidney, heart, and kidney-pancreas transplant patients; Prophylaxis (A, P) | Oral formulation; Tablet formulation; Small molecule therapeutic; Prodrug; Oral liquid formulation | 175865-59-5 | CMV retinitis;Ulcerative colitis;Cytomegalovirus infection |
| zoledronic acid唑来膦酸 | ZOMETA | NOVARTIS RX | Antiosteoporotic; Antipagetic; Bone Resorption Inhibitor | Other Drugs For Disorders Of The Musculo-Skeletal System | Parenteral | Injectable | 2-Mar-13 | | 1-Aug-86 | 24-Jul-07 | Bone metastasis - Solid tumor configuration (A); Postmenopausal osteoporosis; Prophylaxis (A); Postmenopausal osteoporosis (A); Paget's disease (A); Osteoporosis, Secondary prophylaxis in patients with recent low-trauma hip fracture (A); Osteoporosis, in men (A); Osteoporosis due to corticosteroids; Treatment and Prophylaxis (A); Multiple myeloma (A); Hypercalcemia of malignancy (A) | Enteric coated formulation; Tablet formulation; Small molecule therapeutic; Oral sustained release formulation; Oral formulation; Oral absorption enhancer; Intravenous formulation; Infusion | 165800-06-6 | Bone disease;Rheumatoid arthritis;Postmenopausal osteoporosis;Pagets bone disease;Osteoporosis;Osteogenesis imperfecta;Multiple myeloma;Metastasis;Mesothelioma;Male osteoporosis;Hypercalcemia;Breast tumor;Bone tumor;Bone metastases |
| zolmitriptan佐米曲普坦 | ZOMIG | ASTRAZENECA | Antimigraine; Serotonin Receptor Agonist | Analgesics | Nasal;Oral | Spray;Tablet, Orally Disintegrating;Tablet | 14-May-13 | | 7-Jun-90 | 21-Mar-12 | Migraine (A) | Nasal systemic formulation; Transdermal formulation; Tablet formulation; Small molecule therapeutic; Patch formulation; Oral quick release formulation; Oral formulation | 139264-17-8 | Cluster headache;Migraine |
|手机版|药群论坛
( 蜀ICP备15007902号 )
